In their July 2018 Editor's Choice article, "Assessment of a panel of cellular biomarkers and the kinetics of their induction in comparing genotoxic modes of action in HepG2 cells," Kopp et al. report changes in a panel of phosphoprotein biomarkers induced by treatment with clastogens.
